Elaine K. Perry

33.0k citations

185 papers · 18.6k indexed · 5 hit papers · h-index 70

Molecular Biology top 1%
Pharmacology top 0.05%
Cellular and Molecular Neuroscience top 0.1%
Physiology top 0.2%
Psychiatry and Mental health top 0.2%

Co-authors: Robert H. Perry G. Blessed B.E. Tomlinson Andrew Fairbairn Ian G. McKeith B. E. Tomlinson Peter H. Gibson Clive Ballard
Topics: Cholinesterase and Neurodegenerative Diseases (66 papers)Neuroscience and Neuropharmacology Research (59 papers)Nicotinic Acetylcholine Receptors Study (51 papers)
Cited by: Pharmacology Cellular and Molecular Neuroscience Complementary and alternative medicine
Journals: The Lancet NeuroImage American Journal of Psychiatry
Partner nations: United Kingdom United States Australia

In The Last Decade

Elaine K. Perry

184 papers receiving 17.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1978 1.6k citations Elaine K. Perry, B. E. Tomlinson et al. BMJ profile →
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

2008 890 citations Elaine K. Perry et al. profile →
Neurotransmitter enzyme abnormalities in senile dementia

1977 585 citations Elaine K. Perry, Peter H. Gibson et al. profile →
THE CHOLINERGIC HYPOTHESIS—TEN YEARS ON

1986 485 citations Elaine K. Perry profile →
CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

1978 469 citations Elaine K. Perry, R. H. Perry et al. Neuropathology and Applied Neurobiology profile →

Peers

Countries citing papers authored by Elaine K. Perry

Since Specialization

Citations

This map shows the geographic impact of Elaine K. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine K. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine K. Perry more than expected).

Fields of papers citing papers by Elaine K. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine K. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine K. Perry. The network helps show where Elaine K. Perry may publish in the future.

Co-authorship network of co-authors of Elaine K. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine K. Perry. A scholar is included among the top collaborators of Elaine K. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine K. Perry. Elaine K. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease 2014 ·Biological Psychiatry ·Antigoni Ekonomou,George M. Savva,Carol Brayne,Gillian Forster,Paul T. Francis,Mary Ann Johnson,Elaine K. Perry,Johannes Attems,Alyma Somani,Stephen Minger,Clive Ballard	65
2	An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers 2008 ·Psychopharmacology ·Andrew Scholey,(unknown),Clive Ballard,Keith Wesnes,Andrea Tasker,Elaine K. Perry,David O. Kennedy	107
3	Muscarinic acetylcholine receptor status in Alzheimer’s disease assessed using (R, R) 123I-QNB SPECT 2007 ·Journal of Neurology ·Sanjeet Pakrasi,Sean J. Colloby,Michael Firbank,Elaine K. Perry,D. Wyper,Janel E. Owens,Ian G. McKeith,E. D. Williams,John T. O’Brien	24
4	Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline 2007 ·Synapse ·Margaret A. Piggott,Clive Ballard,Elise Rowan,Clive Holmes,Ian G. McKeith,Evelyn Jaros,Robert H. Perry,Elaine K. Perry	13
5	In vitro anti‐β‐secretase and dual anti‐cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia 2004 ·Phytotherapy Research ·Edward J. Okello,Sergey U. Savelev,Elaine K. Perry	82
6	Medicinal Plants and Alzheimer's Disease: Integrating Ethnobotanical and Contemporary Scientific Evidence 1998 ·The Journal of Alternative and Complementary Medicine ·Elaine K. Perry,Anne T. Pickering,Wei Wei Wang,Peter J. Houghton,Nicolette S L Perry	87
7	Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease 1998 ·Biological Psychiatry ·Margaret A. Piggott,Elaine K. Perry,Elizabeth F. Marshall,Ian G. McKeith,Mary K. Johnson,Heather L. Melrose,J.A. Court,Stephen Lloyd,Andrew Fairbairn,Andrew Brown,Paul M. Thompson,Robert H. Perry	49
8	The role of the cholinergic system in the development of the human cerebellum 1995 ·Developmental Brain Research ·J.A. Court,Elaine K. Perry,Dean Spurden,Martin Griffiths,Janet Kerwin,Christopher M. Morris,Michele H. Johnson,Arthur E. Oakley,N.J.M. Birdsall,F. Clementi,Robert H. Perry	53
9	Regional patterns of cholinergic and glutamate activity in the developing and aging human brain 1993 ·Developmental Brain Research ·J.A. Court,Elaine K. Perry,Martin H. Johnson,Margaret A. Piggott,(unknown),R. H. Perry,Paul G. Ince	64
10	Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus 1993 ·Hippocampus ·Elaine K. Perry,J.A. Court,Mary Johnson,Carthage J. Smith,Victoria A. James,(unknown),Janet Kerwin,Christopher M. Morris,Margaret A. Piggott,J.A. Edwardson,N.J.M. Birdsall,Timothy J. Turner,Robert H. Perry	24
11	Dementia: The neurochemical basis of putative transmitter orientated therapy 1991 ·Pharmacology & Therapeutics ·J.A. Court,Elaine K. Perry	40
12	Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations 1991 ·Biological Psychiatry ·A. Leake,Elaine K. Perry,Robert H. Perry,Sabiha Jabeen,Andrew Fairbairn,Ian G. McKeith,I. Nicol Ferrier	26
13	Distribution of neurofibrillary tangle formation and [³H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease 1990 ·Neuropathology and Applied Neurobiology ·John H. Xuereb,J. Candy,Elaine K. Perry,R. H. Perry,Elizabeth Marshall,James R. Bonham	8
14	Fimbria-fornix lesions in aged rats cause increased carbachol-stimulated phosphoinositide hydrolysis in the hippocampus, but no change in muscarinic receptor binding 1990 ·Brain Research ·J.A. Court,Alexander B. Keith,Janet Kerwin,Elaine K. Perry	4
15	Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression 1990 ·Biological Psychiatry ·A. Leake,Elaine K. Perry,Robert H. Perry,Andrew Fairbairn,I. Nicol Ferrier	39
16	Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro 1988 ·Neuroscience Letters ·Elaine K. Perry,(unknown),J.A. Court,James R. Bonham,(unknown),John Atack	66
17	Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. 1987 ·Journal of Neurology Neurosurgery & Psychiatry ·Elaine K. Perry,R. H. Perry,(unknown),D J Dick,J. Candy,J.A. Edwardson,Andrew Fairbairn,G. Blessed	139
18	Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases 1987 ·Neuroscience Letters ·A.J. Cross,P. Slater,M.D.C. Simpson,(unknown),J.F.W. Deakin,R. H. Perry,Elaine K. Perry	41
19	Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease 1981 ·BMJ ·A.J. Cross,Timothy J. Crow,Elaine K. Perry,Robert H. Perry,G. Blessed,B.E. Tomlinson	211
20	Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.breakdown → 1978 ·BMJ ·Elaine K. Perry,B. E. Tomlinson,G. Blessed,K. Bergmann,Peter H. Gibson,Robert H. Perry	1620

About Elaine K. Perry

Elaine K. Perry is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Complementary and alternative medicine, having authored 185 papers that have together received 18.6k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (66 papers), Neuroscience and Neuropharmacology Research (59 papers) and Nicotinic Acetylcholine Receptors Study (51 papers). The work is most often cited by research in Pharmacology (5.5k citations), Cellular and Molecular Neuroscience (5.4k citations) and Complementary and alternative medicine (2.2k citations). Elaine K. Perry has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert H. Perry, G. Blessed, B.E. Tomlinson, Andrew Fairbairn, Ian G. McKeith, B. E. Tomlinson, Peter H. Gibson, Clive Ballard, J.A. Court and Garry Blessed. Their work appears in journals such as The Lancet, NeuroImage and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact